Request that the FDA issue appropriate labeling and risk communication requirements for systemic fluoroquinolone antibiotics
🏛 Food and Drug Administration (FDA)FDA-2026-P-5116
Documents
9
Total comments
183
4 awaiting analysis
Comment status
Open
Last activity
Jul 29, 2026
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Other· Jun 25, 2026No comment period
- Other· Jun 17, 2026No comment period
- Other· May 11, 2026No comment period💬 183